Write from this board Add posts Share
Loading the board
Loading the board
80 posts from @bmsnews, Jan 2025 to Aug 2026: a typical post earns 14 likes and 2 replies. That is more than 70% of the 275 other S&P 500 companies we hold content for. About 1 in 4 of their posts opens with a number.
| Post | Topic | Likes | Replies | Reposts | Score | Posted | Actions |
|---|---|---|---|---|---|---|---|
| @bmsnewsToday, we announced a global strategic partnership with @BioNTech_Group to co-develop and … | General | 46 | 2 | — | 17 | ||
| @bmsnews#MEDIA: Announcing the final analysis of OS from the CheckMate -816 trial evaluating our #… | Science | 42 | 13 | — | 21 | ||
| @bmsnews#MEDIA: Today, we announced a $2.3 billion investment to build a new manufacturing campus … | General | 41 | 2 | — | 19 | ||
| @bmsnews#MEDIA Announcing our first-of-its-kind RayzeBio site in Indianapolis, a cutting-edge U.S.… | General | 34 | 3 | — | 15 | ||
| @bmsnews#MEDIA: The U.S. FDA approved an update to the required echo monitoring for our first-in-c… | General | 28 | 29 | — | 23 | ||
| @bmsnews#MEDIA: @US_FDA granted accelerated approval to our new CELMoD treatment for relapsed or r… | General | 26 | 4 | — | 17 | ||
| @bmsnewsMEDIA: The @US_FDA has granted Breakthrough Therapy Designation to our investigational EGF… | General | 26 | 4 | — | 14 | ||
| @bmsnews#MEDIA: @US_FDA has approved the removal of REMS and streamlined patient monitoring requir… | General | 25 | 1 | — | 12 | ||
| @bmsnews#MEDIA: Announcing the @US_FDA has granted priority review of the application for our #imm… | General | 24 | 7 | — | 17 | ||
| @bmsnews#MEDIA: Announcing @US_FDA has accepted the application for our dual #immunotherapy combin… | General | 24 | 1 | — | 12 |